SARS-CoV-2 - Chloroquine - Therapeutic Candidates

SARS-CoV-2 - Chloroquine - Therapeutic Candidates

 

Chloroquine (also called chloroquinine) is an antimalarial drug of the 4-aminoquinoline family that has been widely marketed as salts (sulphate or phosphate). Chloroquine, quinine and hydroxychloroquine are the most widely used treatments against malaria, both preventive and curative. This molecule has also shown efficacy in the treatment of certain autoimmune diseases such as lupus and rheumatoid diseases such as rheumatoid arthritis. Chloroquine also shows antiviral effects, although for the time being these have mainly been observed in vitro.
With the COVID-19 pandemic caused by the SARS-CoV-2 virus, chloroquine has attracted interest, along with other molecules, as a potential antiviral. Chloroquine is believed to be effective in vitro in inhibiting the replication of SARS-CoV-2. Chloroquine appears to be responsible for raising the pH of the lysosomes of cells targeted by the virus. However, the efficacy of chloroquine as a treatment in patients infected with CoV-2-SARS has yet to be proven but many studies are ongoing. 

 

 

Search result : 320 product found

Refine your search :

RUOCE / IVD
  • Unconjugated 28
  • [3H] 1
  • Biochemicals 254
  • Inhibitor/Antagonist/Agonist 63
  • Protein/peptide 2
  • Radiochemicals 1
  • Assay 3
APPLY FILTERS
REINITIALIZE


Cat#
Description
Cond.
Price Bef. VAT
orb1298213-200mg
 200mg 
B4874-1ml
 10mM(in1mLH2O) 
orb1219060-10mg
 10mg 
orb1713835-10mg
 10mg 
orb1219060-5mg
 5mg 
orb1298213-100mg
 100mg 
orb1298213-500mg
 500mg 
orb1713834-50mg
 50mg 
orb340338-250mg
 250mg 
orb1895639
 10mm 
orb1310137-100mg
 100mg 
orb1895638-50mg
 50mg 
orb1310137-50mg
 50mg 
orb1224083-50mg
 50mg 
orb1224083-100mg
 100mg 
orb340338-50mg
 50mg 
orb1224083-25mg
 25mg 
orb1224083-200mg
 200mg 
orb1895640-10mg
 10mg 
orb1227539-250mg
 250mg